Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

32.80
-0.1700-0.52%
Volume:791.33K
Turnover:25.95M
Market Cap:3.79B
PE:-10.28
High:33.17
Open:32.19
Low:32.15
Close:32.97
52wk High:43.15
52wk Low:18.92
Shares:115.55M
Float Shares:110.00M
Volume Ratio:0.38
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1920
EPS(LYR):-3.1920
ROE:-47.34%
ROA:-30.27%
PB:5.93
PE(LYR):-10.28

Loading ...

Feb 11, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2026

Major Issues Report

Form 8-K - Current report
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 23, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 22, 2025

Major Issues Report

Form 8-K - Current report
Aug 19, 2025

Major Issues Report

Form 8-K - Current report
Jul 23, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 23, 2025

Major Issues Report

Form 8-K - Current report
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 27, 2025

Major Issues Report

Form 8-K - Current report
Apr 24, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]